Merck, Schering Suspend TV Ads Touting Vytorin

Law360, New York (January 23, 2008, 12:00 AM EST) -- Merck & Co. and Schering-Plough Corp. are yanking television ads for Vytorin amid proposed class actions and a congressional inquiry on the effectiveness of the cholesterol drug.

The companies said Tuesday that they had decided to voluntarily and temporarily suspend direct-to-consumer broadcast advertising of Vytorin, which combines Zetia and Zocor, the Associated Press reported.

The decision came in the wake of public outcry after a study showed last week that Vytorin is not more effective than Zocor at reducing fat deposits in arteries. Zocor is Merck’s...
To view the full article, register now.